These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18362243)

  • 1. Macrophage migration inhibitory factor in cardiovascular disease.
    Zernecke A; Bernhagen J; Weber C
    Circulation; 2008 Mar; 117(12):1594-602. PubMed ID: 18362243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
    Noels H; Bernhagen J; Weber C
    Trends Cardiovasc Med; 2009 Apr; 19(3):76-86. PubMed ID: 19679264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
    Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C
    Nat Med; 2007 May; 13(5):587-96. PubMed ID: 17435771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.
    Asare Y; Schmitt M; Bernhagen J
    Thromb Haemost; 2013 Mar; 109(3):391-8. PubMed ID: 23329140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
    Santos LL; Morand EF
    Clin Chim Acta; 2009 Jan; 399(1-2):1-7. PubMed ID: 18838066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
    Ayoub S; Hickey MJ; Morand EF
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):98-105. PubMed ID: 18235539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
    Morand EF; Leech M; Bernhagen J
    Nat Rev Drug Discov; 2006 May; 5(5):399-410. PubMed ID: 16628200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophage migration inhibitory factor (MIF) in the skin.
    Shimizu T
    J Dermatol Sci; 2005 Feb; 37(2):65-73. PubMed ID: 15659324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
    Santos LL; Morand EF
    Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
    Morand EF
    Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
    Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in atherosclerosis: an update.
    Zernecke A; Shagdarsuren E; Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders.
    Ohkawara T; Nishihira J; Takeda H; Asaka M; Sugiyama T
    J Gastroenterol; 2005 Feb; 40(2):117-22. PubMed ID: 15770393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor and glucocorticoid sensitivity.
    Aeberli D; Leech M; Morand EF
    Rheumatology (Oxford); 2006 Aug; 45(8):937-43. PubMed ID: 16705047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor and its role in autoimmune diseases.
    Denkinger CM; Metz C; Fingerle-Rowson G; Denkinger MD; Forsthuber T
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):389-400. PubMed ID: 15577740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIF in autoimmunity and novel therapeutic approaches.
    Stosic-Grujicic S; Stojanovic I; Nicoletti F
    Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF: a key player in cutaneous biology and wound healing.
    Gilliver SC; Emmerson E; Bernhagen J; Hardman MJ
    Exp Dermatol; 2011 Jan; 20(1):1-6. PubMed ID: 21158933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings.
    Dayawansa NH; Gao XM; White DA; Dart AM; Du XJ
    Clin Sci (Lond); 2014 Aug; 127(3):149-61. PubMed ID: 24697297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MIF in inflammation and tumorigenesis.
    Bach JP; Rinn B; Meyer B; Dodel R; Bacher M
    Oncology; 2008; 75(3-4):127-33. PubMed ID: 18791328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel mediator--macrophage migration inhibitory factor].
    Nishihira J
    Nihon Rinsho; 2004 Dec; 62(12):2205-11. PubMed ID: 15597786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.